From research question
to screened evidence table.
From a research question to a screened, exportable evidence table with PRISMA flow and journal recommendations — free, in minutes, not days.
1 Build a search
Start with a research question (the AI will translate it into an optimized PubMed query) or enter terms manually. Specialty quick-starts let you pre-load the right MeSH context, and the Advanced panel adds date period and study-type filters (RCT, systematic review, in vitro, preprints…).
2 Refine by content (MeSH + keywords)
After fetching metadata, EvidenceScope extracts MeSH terms and title keywords from your results, ranked by frequency. Drag terms into ALL of these, ANY of these, or NONE of these zones to refine the set with boolean logic — without rewriting your PubMed query.
3 Filter by impact & citations
Keep only the highest-impact journals with a single choice — Top 10%, Top 25%, or All. Powered by OpenAlex (2-year mean citedness, 250K+ journals — live API) with SCImago SJR as fallback. Add a citation-count cutoff (NIH iCite) with an interactive histogram to prioritise papers that have already been cited.
4 Browse results
Each result shows title, authors, journal, impact factor, quartile, year, PMID, and an expandable abstract. Click Include or Exclude to screen each article — or use Include all to bulk-screen. Open-access articles in PubMed Central get a Figures & tables button for AI extraction.
5 AI Enrichment (PICO)
One click extracts structured data per article: Population, Intervention, Comparison, Outcome (PICO), plus study design, sample size, country, and a one-line bottom-line takeaway. Powered by Claude — no manual data extraction.
6 PRISMA flow diagram
Auto-generated PRISMA 2020 flow diagram showing search-to-inclusion numbers — directly downloadable as SVG, alongside your evidence table. No more drawing it manually in PowerPoint.
7 Export to Excel
Export the full dataset to Excel with every column: title, authors, journal, year, PMID, IF, quartile, citations, screening status, PICO, study design, sample size, country, abstract. Figures and tables extracted from open-access articles download separately as Word.
| PMID | Title | Journal | IF | Design | Population | Citations |
|---|---|---|---|---|---|---|
| 38456123 | Mitochondrial dysfunction in sepsis… | Nature Medicine | 58.7 | RCT | ICU adults n=248 | 142 |
| 38221045 | Mitochondria-targeted therapies… | Critical Care Medicine | 8.8 | Review | N/A | 76 |
| 37892341 | Reactive oxygen species… | Intensive Care Medicine | 41.3 | Cohort | Septic shock n=142 | 58 |
8 Journal Finder
A separate workflow: paste your manuscript title + abstract and EvidenceScope finds the most relevant journals by analyzing where similar published papers appear. Each journal is enriched with CiteScore, H-index, OA status, APC cost, and the Dutch University deal (free APC for VSNU institutions: RUG, EUR, RU, UL, UM, UU, UvA, VU, WUR).
| # | Journal | Publisher | CiteScore | H-idx | OA | NL deal | Hits |
|---|---|---|---|---|---|---|---|
| 1 | Critical Care Medicine Critical Care Medicine, Emergency Medicine | Wolters Kluwer | 8.8 | 253 | Hybrid | Free | 14 |
| 2 | Intensive Care Medicine Critical Care Medicine, Anesthesiology | Springer | 41.3 | 221 | Hybrid | Free | 9 |
| 3 | Shock Critical Care, Surgery, Hematology | Wolters Kluwer | 5.8 | 156 | Hybrid | Free | 8 |
| 4 | Mitochondrion Cell Biology, Biochemistry | Elsevier | 7.4 | 132 | Hybrid | 15% discount | 7 |
| 5 | Free Radical Biology and Medicine Biochemistry, Cell Biology | Elsevier | 10.6 | 230 | Hybrid | 15% discount | 6 |
| 6 | Frontiers in Immunology Immunology, Microbiology | Frontiers | 11.0 | 191 | OA | Free | 5 |
9 Ask literature
Ask a clinical or research question in plain language and get a grounded, cited answer — every claim linked to a real PubMed article, with the sources listed. EvidenceScope searches the literature for you, so the answer is traceable, never invented.
Current evidence is promising but limited. A multicentre RCT (n=248) found the mitochondria-targeted antioxidant MitoQ improved 28-day survival from 56% to 71% (HR 0.62, 95% CI 0.43–0.89) PMID 38456123. A mechanistic cohort linked mitochondrial membrane-potential collapse to subsequent organ failure PMID 37892341, but larger confirmatory trials are still needed before routine use…
Ready to try it on your own research?
Completely free, no paid plans. Search, filter, screen, and export are unlimited; AI features (query builder, PICO enrich, Ask literature) have a generous daily fair-use cap.